Yorktown Management & Research Company’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-900
Closed -$308K 223
2023
Q2
$308K Hold
900
0.33% 150
2023
Q1
$230K Hold
900
0.25% 178
2022
Q4
$239K Buy
+900
New +$219K 0.29% 171
2022
Q2
Sell
-900
Closed -$272K 211
2022
Q1
$272K Hold
900
0.23% 172
2021
Q4
$323K Hold
900
0.22% 168
2021
Q3
$298K Hold
900
0.22% 175
2021
Q2
$276K Hold
900
0.22% 188
2021
Q1
$222K Buy
+900
New +$226K 0.18% 227
2020
Q4
Sell
-1,500
Closed -$355K 237
2020
Q3
$355K Hold
1,500
0.33% 143
2020
Q2
$285K Hold
1,500
0.26% 208
2020
Q1
$248K Buy
+1,500
New +$275K 0.25% 166
2019
Q2
Sell
-1,680
Closed -$320K 326
2019
Q1
$320K Hold
1,680
0.1% 236
2018
Q4
$268K Hold
1,680
0.09% 251
2018
Q3
$321K Buy
+1,680
New +$298K 0.09% 252
2013
Q3
Sell
-3,600
Closed -$203K 379
2013
Q2
$203K Buy
+3,600
New +$198K 0.04% 288

Other funds holding ISRG

Yorktown Management & Research Company's ISRG Position: Q3 2023 in Review

Yorktown Management & Research Company sold out of Intuitive Surgical (ISRG) in Q3 2023, closing a stake of 900 shares — an estimated $308K sold.

Yorktown Management & Research Company first reported a position in ISRG in Q2 2013 and held it in 15 quarters. The position peaked at $355K in Q3 2020. 1,549 funds tracked by Wall St. Rank hold ISRG as of Q3 2023.

  • Yorktown Management & Research Company reported no remaining Intuitive Surgical position as of Q3 2023 after selling out during the quarter.
  • Yorktown Management & Research Company sold 900 Intuitive Surgical shares in Q3 2023, an estimated $308K.
  • Yorktown Management & Research Company first reported a position in Intuitive Surgical in Q2 2013 and held it in 15 quarters.
  • Yorktown Management & Research Company's Intuitive Surgical position peaked at $355K in Q3 2020.
  • 1,549 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2023.

Based on Yorktown Management & Research Company's 13F filing for Q3 2023, filed 26 Oct 2023.